American Journal of Kidney Diseases

Slides:

Advertisements

Similar presentations

Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.

Advertisements

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Renal Function Testing

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

American Journal of Kidney Diseases

Peritoneal dialysis American Journal of Kidney Diseases

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson, MD, MPH, Weiling Wang,

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

A Decade After the KDOQI CKD Guidelines

Cardiovascular Disease and CKD: Core Curriculum 2010

Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study Rebecca A. Spicer, MBChB, Philip A. Clayton,

From Static to Dynamic Risk Prediction: Time Is Everything

Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial Hao Yan, MD, Wei Fang, MD,

Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): Nutrition guidelines, indicators, and.

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

Shared Primacy of Sodium and Potassium on Cardiovascular Risk

Howell S.J. , Sear J.W. , Foëx P British Journal of Anaesthesia

American Journal of Kidney Diseases

Kidney Tattoos American Journal of Kidney Diseases

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Erratum American Journal of Kidney Diseases

National Kidney Foundation American Journal of Kidney Diseases

Salt and Hypertension American Journal of Kidney Diseases

David Rosenthal, MD, Edgar Borrero, MD, Michael D. Clark, MD, Pano A

Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.

A Decade After the KDOQI CKD Guidelines: A Historical Perspective

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

On Statin Treatment to Prevent Sepsis in Dialysis Patients

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Valve replacement surgery for older individuals with preoperative atrial fibrillation: The effect of prosthetic valve choice and surgical ablation Ho.

American Journal of Kidney Diseases

Polyunsaturated Fatty Acids and Kidney Disease

Rajiv Saran, MD, MS, Bernard J. Canaud, MD, Thomas A

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Lars G. Svensson, MD, PhD, E. Stanley Crawford, MD †, Kenneth R

CPR 1.2.: Evaluation of Anemia in CKD

Risks and Outcomes of Acute Kidney Injury Requiring Dialysis After Cardiac Transplantation Janet M. Boyle, MD, Soundous Moualla, MD, Susana Arrigain,

Cardiovascular complications in chronic kidney disease

Christina L. Klein, MD, Daniel C. Brennan, MD, FACP

American Journal of Kidney Diseases

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Survival by time of day of hemodialysis: analysis of United States renal data system dialysis morbidity and mortality waves III/IV Kevin C Abbott, MD,

Evidence and Outcomes in CKD

The Association of Lipid-Modifying Medications With Mortality in Patients on Long-Term Peritoneal Dialysis Alexander S. Goldfarb-Rumyantzev, MD, PhD,

Kevin L. Greason, MD, Brian D. Lahr, MS, John M

Dennis G. Moledina, MD, Mark A. Perazella, MD

Erratum American Journal of Kidney Diseases

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target American.

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Arnold S. Relman, MD, American Journal of Kidney Diseases

American Journal of Kidney Diseases

Making Music American Journal of Kidney Diseases

Linda M. Reilly, M. D. , Ronald J. Stoney, M. D. , Jerry Goldstone, M

Erratum American Journal of Kidney Diseases

E.Stanley Crawford, M.D., Ralph W. DeNatale, M.D.

The Use of Vaccines in Adult Patients With Renal Disease

This Month in AJKD American Journal of Kidney Diseases

Discussion The Journal of Thoracic and Cardiovascular Surgery

Dialysis Research and N-of-1 Trials: Made for Each Other?

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

A Randomized Controlled Trial of Coiled Versus Straight Swan-Neck Tenckhoff Catheters in Peritoneal Dialysis Patients David W. Johnson, PhD, Jennifer.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Presentation transcript:

American Journal of Kidney Diseases K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients American Journal of Kidney Diseases Volume 45, Pages 16-153 (April 2005) DOI: 10.1053/j.ajkd.2005.01.019 Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 Estimated mortality of dialysis patients after acute MI. Reproduced with permission.7 American Journal of Kidney Diseases 2005 45, 16-153DOI: (10.1053/j.ajkd.2005.01.019) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

Fig 2 Estimated all-cause survival of dialysis patients after CABG, PTCA, and stenting. Bars indicate SEMs. Reprinted with permission (http://lww.com)67 American Journal of Kidney Diseases 2005 45, 16-153DOI: (10.1053/j.ajkd.2005.01.019) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

Fig 3 Estimated all-cause survival of dialysis patients after heart valve replacement surgery with tissue and nontissue prosthetic valves. Bars indicate standard errors. Reprinted with permission (http://lww.com).70 American Journal of Kidney Diseases 2005 45, 16-153DOI: (10.1053/j.ajkd.2005.01.019) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

Fig 4 Hypertension treatment algorithm in dialysis patients. American Journal of Kidney Diseases 2005 45, 16-153DOI: (10.1053/j.ajkd.2005.01.019) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

Fig 5 Kaplan-Meier survival curves by baseline troponin levels. The number of patients at risk at baseline, 1 year, 2 years, and 2.5 years for each cutoff is shown at the bottom of the graph. The 99th percentile refers to the normal reference limit. The 10% CV refers to the lowest concentration that demonstrates a 10% total precision. The ROC cutoff refers to concentrations optimized for the sensitive and specific detection of MI. Reproduced with permission (http://lww.com).411 American Journal of Kidney Diseases 2005 45, 16-153DOI: (10.1053/j.ajkd.2005.01.019) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

Fig 6 Desaturation and elongation of the major families of polyunsaturated fatty acids. Reproduced with permission.8 American Journal of Kidney Diseases 2005 45, 16-153DOI: (10.1053/j.ajkd.2005.01.019) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

Fig 7 Coronary event-free survival and apo(a) phenotypes. Adjusted results are obtained from a multiple Cox proportional hazards regression analysis. Numbers near the survival curves represent the number of patients with HMW and LMW apo(a) phenotypes at risk at the times 0, 12, 24, 36, 48 and 60 months. Reproduced with permission (http://lww.com).603 American Journal of Kidney Diseases 2005 45, 16-153DOI: (10.1053/j.ajkd.2005.01.019) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions